{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:18Z","timestamp":1790873778326,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03312-3","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:56:25Z","timestamp":1769036185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surface Modification of Zinc Undecylenate with Nanoparticle Fluconazole Using Low-Pressure RF Plasma-Assisted CVD: A New Generation Antifungal Compound"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-3567","authenticated-orcid":false,"given":"Nam\u0131k","family":"Bilici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-021X","authenticated-orcid":false,"given":"Ferhat","family":"Bozduman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"3312_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000007136","volume":"44","author":"H Mikamo","year":"1998","unstructured":"Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Tamaya T. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis. Chemotherapy. 1998;44:364\u20138. https:\/\/doi.org\/10.1159\/000007136.","journal-title":"Chemotherapy"},{"key":"3312_CR2","first-page":"20","volume":"43","author":"R Vacheva-Dobrevski","year":"2004","unstructured":"Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N. Comparative study of itraconazole and fluconazole therapy in vaginal candidosis. Akush Ginekol (Sofiia). 2004;43:20\u20133.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"3312_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1742-1241.1995.tb09895.x","volume":"49","author":"PD Woolley","year":"1995","unstructured":"Woolley PD, Higgins SP. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract. 1995;49:65\u20136.","journal-title":"Br J Clin Pract"},{"key":"3312_CR4","doi-asserted-by":"publisher","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265\u201375.  https:\/\/doi.org\/10.1093\/nar\/gkad976.","DOI":"10.1093\/nar\/gkad976"},{"key":"3312_CR5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.22034\/APJCP.2018.19.6.1543","volume":"19","author":"M Pourghasemian","year":"2018","unstructured":"Pourghasemian M, Mehdizadeh M, Hajfathali A, Habibzadeh A, Hosseini MH. The role of fluconazole prophylaxis regimen and the regimes chosen by the patient\u2019s risk of fungal infection in reducing the infection rate after bone marrow transplantation. Asian Pac J Cancer Prev APJCP. 2018;19:1543\u20136. https:\/\/doi.org\/10.22034\/APJCP.2018.19.6.1543.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"3312_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF00199872","volume":"46","author":"W Inman","year":"1994","unstructured":"Inman W, Pearce G, Wilton L. Safety of fluconazole in the treatment of vaginal candidiasis: A prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol. 1994;46:46. https:\/\/doi.org\/10.1007\/BF00199872.","journal-title":"Eur J Clin Pharmacol."},{"key":"3312_CR7","first-page":"30","volume":"42","author":"V Mazne\u0131kova","year":"2003","unstructured":"Mazne\u0131kova V. Vaginal candidiasis\u2014treatment protocols using miconazole and fluconazole. Akush Ginekol (Sofiia). 2003;42:30\u20134.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"3312_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/myc.12292","volume":"58","author":"W Mendling","year":"2015","unstructured":"Mendling W. Guideline: vulvovaginal candidosis (AWMF 015\/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses. 2015;58:1\u201315. https:\/\/doi.org\/10.1111\/myc.12292.","journal-title":"Mycoses"},{"key":"3312_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10647440500240615","volume":"13","author":"LS Seidman","year":"2005","unstructured":"Seidman LS, Skokos CK. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect Dis Obstet Gynecol. 2005;13:197\u2013206. https:\/\/doi.org\/10.1080\/10647440500240615.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"3312_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.chroma.2005.10.058","volume":"1119","author":"M-C Lin","year":"2006","unstructured":"Lin M-C, Wu H-L, Kou H-S, Wu S-M. Simple fluorimetric liquid chromatographic method for the analysis of undecylenic acid and zinc undecylenate in pharmaceutical preparations. J Chromatogr A. 2006;1119:264\u20139. https:\/\/doi.org\/10.1016\/j.chroma.2005.10.058.","journal-title":"J Chromatogr A"},{"key":"3312_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-4362.1983.tb01215.x","volume":"22","author":"F Battistini","year":"1983","unstructured":"Battistini F, Cordero C, Urcuyo FG, Rojas RF, Ollague W, Zaias N. The treatment of dermatophytoses of the glabrous skin: a comparison of undecylenic acid and its salt versus tolnaftate. Int J Dermatol. 1983;22:388\u20139. https:\/\/doi.org\/10.1111\/j.1365-4362.1983.tb01215.x.","journal-title":"Int J Dermatol"},{"key":"3312_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ijms19010184","volume":"19","author":"M Petrovi\u0107","year":"2018","unstructured":"Petrovi\u0107 M, Bonvin D, Hofmann H, Mioni\u0107 EM. Fungicidal PMMA-undecylenic acid composites. Int J Mol Sci. 2018;19:184. https:\/\/doi.org\/10.3390\/ijms19010184.","journal-title":"Int J Mol Sci"},{"key":"3312_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5414\/CP202460","volume":"54","author":"D Shi","year":"2016","unstructured":"Shi D, Zhao Y, Yan H, Fu H, Shen Y, Lu G, et al. Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans. Int J Clin Pharmacol Ther. 2016;54:343\u201353. https:\/\/doi.org\/10.5414\/CP202460.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3312_CR14","unstructured":"Gambin JPD. Desenvolvimento de uma nanoemuls\u00e3o contendo fluconazol e timol preparada via t\u00e9cnica de emulsifica\u00e7\u00e3o espont\u00e2nea visando aplica\u00e7\u00e3o t\u00f3pica contra cepas de Candida spp. Universidade Federal de Santa Catarina. 2023. https:\/\/repositorio.ufsc.br\/handle\/123456789\/254172. Accessed 9 Aug 2025."},{"key":"3312_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s43088-022-00335-8","volume":"11","author":"K Ahmad","year":"2022","unstructured":"Ahmad K, Khan S, Afridi M, Hassan A, Shah MM, Rasheed H, et al. Marine macroalgae polysaccharides-based nanomaterials: an overview with respect to nanoscience applications. Beni-Suef Univ J Basic Appl Sci. 2022;11:156. https:\/\/doi.org\/10.1186\/s43088-022-00335-8.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"3312_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16091114","volume":"16","author":"A Karnwal","year":"2024","unstructured":"Karnwal A, Sharma V, Kumar G, Jassim AY, Dohroo A, Sivanesan I. Transforming medicine with nanobiotechnology: nanocarriers and their biomedical applications. Pharmaceutics. 2024;16: 1114. https:\/\/doi.org\/10.3390\/pharmaceutics16091114.","journal-title":"Pharmaceutics"},{"key":"3312_CR17","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1002\/slct.202103418","volume":"6","author":"M Qindeel","year":"2021","unstructured":"Qindeel M, Sargazi S, Hosseinikhah SM, Rahdar A, Barani M, Thakur VK, et al. Porphyrin\u2010based nanostructures for cancer theranostics: chemistry, fundamentals and recent advances. ChemistrySelect. 2021;6:14082\u201399. https:\/\/doi.org\/10.1002\/slct.202103418.","journal-title":"ChemistrySelect"},{"key":"3312_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.colsurfb.2016.03.013","volume":"142","author":"M Moazeni","year":"2016","unstructured":"Moazeni M, Kelidari HR, Saeedi M, Morteza-Semnani K, Nabili M, Gohar AA, et al. Time to overcome fluconazole resistant Candida isolates: solid lipid nanoparticles as a novel antifungal drug delivery system. Colloids Surf B Biointerfaces. 2016;142:400\u20137. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.03.013.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3312_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102437","volume":"63","author":"P Kraisit","year":"2021","unstructured":"Kraisit P, Hirun N, Mahadlek J, Limmatvapirat S. Fluconazole-loaded solid lipid nanoparticles (SLNs) as a potential carrier for buccal drug delivery of oral candidiasis treatment using the Box-Behnken design. J Drug Deliv Sci Technol. 2021;63: 102437. https:\/\/doi.org\/10.1016\/j.jddst.2021.102437.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3312_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12247-018-9335-z","volume":"14","author":"AAH Abdellatif","year":"2019","unstructured":"Abdellatif AAH, El-Telbany DFA, Zayed G, Al-Sawahli MM. Hydrogel containing PEG-coated fluconazole nanoparticles with enhanced solubility and antifungal activity. J Pharm Innov. 2019;14:112\u201322. https:\/\/doi.org\/10.1007\/s12247-018-9335-z.","journal-title":"J Pharm Innov"},{"key":"3312_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1155622","volume":"14","author":"KA Altammar","year":"2023","unstructured":"Altammar KA. A review on nanoparticles: characteristics, synthesis, applications, and challenges. Front Microbiol. 2023;14: 1155622. https:\/\/doi.org\/10.3389\/fmicb.2023.1155622.","journal-title":"Front Microbiol"},{"key":"3312_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2024.1456939","volume":"6","author":"P-D Ly","year":"2024","unstructured":"Ly P-D, Ly K-N, Phan H-L, Nguyen HHT, Duong V-A, Nguyen HV. Recent advances in surface decoration of nanoparticles in drug delivery. Front Nanotechnol. 2024;6: 1456939. https:\/\/doi.org\/10.3389\/fnano.2024.1456939.","journal-title":"Front Nanotechnol"},{"key":"3312_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpb.2020.01.017","volume":"149","author":"G Alp","year":"2020","unstructured":"Alp G, Aydogan N. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer. Eur J Pharm Biopharm. 2020;149:45\u201357. https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.017.","journal-title":"Eur J Pharm Biopharm"},{"key":"3312_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpb.2017.12.017","volume":"124","author":"N Nafee","year":"2018","unstructured":"Nafee N, Forier K, Braeckmans K, Schneider M. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: proof of concept, challenges and pitfalls. Eur J Pharm Biopharm. 2018;124:125\u201337. https:\/\/doi.org\/10.1016\/j.ejpb.2017.12.017.","journal-title":"Eur J Pharm Biopharm"},{"key":"3312_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/nano10040787","volume":"10","author":"SY Fam","year":"2020","unstructured":"Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials. 2020;10: 787. https:\/\/doi.org\/10.3390\/nano10040787.","journal-title":"Nanomaterials"},{"key":"3312_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/gels6010006","volume":"6","author":"F Pinelli","year":"2020","unstructured":"Pinelli F, Perale G, Rossi F. Coating and functionalization strategies for nanogels and nanoparticles for selective drug delivery. Gels. 2020;6: 6. https:\/\/doi.org\/10.3390\/gels6010006.","journal-title":"Gels"},{"key":"3312_CR27","doi-asserted-by":"publisher","first-page":"102104","DOI":"10.1016\/j.jsps.2024.102104","volume":"32","author":"BN Aldosari","year":"2024","unstructured":"Aldosari BN, Ibrahim MA, Alqahtani Y, Abou El Ela AESF. Formulation and evaluation of fluconazole nanosuspensions: in vitro characterization and transcorneal permeability studies. Saudi Pharm J. 2024;32:102104. https:\/\/doi.org\/10.1016\/j.jsps.2024.102104.","journal-title":"Saudi Pharm J"},{"key":"3312_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28227508","volume":"28","author":"A Samee","year":"2023","unstructured":"Samee A, Usman F, Wani TA, Farooq M, Shah HS, Javed I, et al. Sulconazole-loaded solid lipid nanoparticles for enhanced antifungal activity: in vitro and in vivo approach. Molecules. 2023;28: 7508. https:\/\/doi.org\/10.3390\/molecules28227508.","journal-title":"Molecules"},{"key":"3312_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4155\/tde-2016-0040","volume":"7","author":"S Trombino","year":"2016","unstructured":"Trombino S, Mellace S, Cassano R. Solid lipid nanoparticles for antifungal drugs delivery for topical applications. Ther Deliv. 2016;7:639\u201347. https:\/\/doi.org\/10.4155\/tde-2016-0040.","journal-title":"Ther Deliv"},{"key":"3312_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5530\/ijper.58.1.13","volume":"58","author":"G Meravanige","year":"2024","unstructured":"Meravanige G. Design and development of anti-fungal topical gel loaded with solid lipid nanoparticles for wound healing. Indian J Pharm Educ Res. 2024;58:131\u20138. https:\/\/doi.org\/10.5530\/ijper.58.1.13.","journal-title":"Indian J Pharm Educ Res"},{"key":"3312_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.colsurfb.2018.12.011","volume":"175","author":"M Domingues Bianchin","year":"2019","unstructured":"Domingues Bianchin M, Borowicz SM, Da Rosa Monte Machado G, Pippi B, Stanis\u00e7uaski Guterres S, Raffin Pohlmann A, et al. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species. Colloids Surf B Biointerfaces. 2019;175:523\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.12.011.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3312_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","volume":"25","author":"S El-Housiny","year":"2018","unstructured":"El-Housiny S, Shams Eldeen MA, El-Attar YA, Salem HA, Attia D, Bendas ER, et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. Drug Deliv. 2018;25:78\u201390. https:\/\/doi.org\/10.1080\/10717544.2017.1413444.","journal-title":"Drug Deliv"},{"key":"3312_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/709152","volume":"2014","author":"M Gupta","year":"2014","unstructured":"Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:1\u201311. https:\/\/doi.org\/10.1155\/2014\/709152.","journal-title":"Dermatol Res Pract"},{"key":"3312_CR34","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1177\/10915818241227124","volume":"43","author":"LN Scott","year":"2024","unstructured":"Scott LN, Fiume M, Zhu J, Bergfeld WF, Belsito DV, Hill RA, et al. Safety assessment of zinc salts as used in cosmetics. Int J Toxicol. 2024;43:5S-69S. https:\/\/doi.org\/10.1177\/10915818241227124.","journal-title":"Int J Toxicol"},{"key":"3312_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cvde.200606554","volume":"13","author":"M Camero","year":"2007","unstructured":"Camero M, Gordillo\u2010V\u00e1zquez FJ, G\u00f3mez\u2010Aleixandre C. Low\u2010pressure PECVD of nanoparticles in carbon thin films from Ar\/H2\/C2H2 plasmas: synthesis of films and analysis of the electron energy distribution function. Chem Vap Deposition. 2007;13:326\u201334. https:\/\/doi.org\/10.1002\/cvde.200606554.","journal-title":"Chem Vap Deposition"},{"key":"3312_CR36","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/257\/1\/012016","volume":"257","author":"YA Lebedev","year":"2010","unstructured":"Lebedev YA. Microwave discharges: generation and diagnostics. J Phys Conf Ser. 2010;257: 012016. https:\/\/doi.org\/10.1088\/1742-6596\/257\/1\/012016.","journal-title":"J Phys Conf Ser"},{"key":"3312_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"R Muller","year":"2000","unstructured":"Muller R. Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u201377. https:\/\/doi.org\/10.1016\/S0939-6411(00)00087-4.","journal-title":"Eur J Pharm Biopharm"},{"key":"3312_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cattod.2022.08.004","volume":"423","author":"A Serrano-Lotina","year":"2023","unstructured":"Serrano-Lotina A, Portela R, Baeza P, Alcolea-Rodriguez V, Villarroel M, \u00c1vila P. Zeta potential as a tool for functional materials development. Catal Today. 2023;423: 113862. https:\/\/doi.org\/10.1016\/j.cattod.2022.08.004.","journal-title":"Catal Today"},{"key":"3312_CR39","unstructured":"NIST Atomic Spectra Database [Internet]. 2025.  https:\/\/physics.nist.gov\/PhysRefData\/ASD\/lines_form.html. Accessed 8 Aug 2025."},{"key":"3312_CR40","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/10837450.2024.2394573","volume":"29","author":"FA Sarhan","year":"2024","unstructured":"Sarhan FA, Soliman ME, Hamza MY, El-Gogary RI. Revolutionizing treatment for topical fungal infections: evaluating penetration-enhancer-containing vesicles as a fluconazole delivery system: ex-vivo and in-vivo dermal testing. Pharm Dev Technol. 2024;29:814\u201323. https:\/\/doi.org\/10.1080\/10837450.2024.2394573.","journal-title":"Pharm Dev Technol"},{"key":"3312_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04663","volume":"6","author":"A Garg","year":"2020","unstructured":"Garg A, Sharma GS, Goyal AK, Ghosh G, Si SC, Rath G. Recent advances in topical carriers of anti-fungal agents. Heliyon. 2020;6: e04663. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04663.","journal-title":"Heliyon"},{"key":"3312_CR42","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.matpr.2016.04.097","volume":"3","author":"K Samrat","year":"2016","unstructured":"Samrat K, Nikhil NS, Karthick Raja Namasivamyam S, Sharath R, Chandraprabha MN, Harish BG, et al. Evaluation of improved antifungal activity of fluconazole \u2013 silver nanoconjugate against pathogenic fungi. Materials Today: Proceedings. 2016;3:1958\u201367. https:\/\/doi.org\/10.1016\/j.matpr.2016.04.097.","journal-title":"Materials Today: Proceedings"},{"key":"3312_CR43","doi-asserted-by":"publisher","DOI":"10.1116\/6.0000511","volume":"15","author":"J Naderi","year":"2020","unstructured":"Naderi J, Giles C, Saboohi S, Griesser HJ, Coad BR. Combatting fungal biofilm formation by diffusive release of fluconazole from heptylamine plasma polymer coating. Biointerphases. 2020;15: 061012. https:\/\/doi.org\/10.1116\/6.0000511.","journal-title":"Biointerphases"},{"key":"3312_CR44","doi-asserted-by":"publisher","first-page":"e202400248","DOI":"10.1002\/slct.202400248","volume":"9","author":"A Das","year":"2024","unstructured":"Das A, Ringu T, Ghosh S, Pramanik N. Polycaprolactone microsphere\u2010encapsulated fluconazole\u2010loaded zinc oxide and hydroxyapatite nanocomposites for enhanced biological performance. ChemSelect. 2024;9:e202400248. https:\/\/doi.org\/10.1002\/slct.202400248.","journal-title":"ChemSelect"},{"key":"3312_CR45","doi-asserted-by":"publisher","first-page":"myad113","DOI":"10.1093\/mmy\/myad113","volume":"61","author":"JT Da Silva","year":"2023","unstructured":"Da Silva JT, de Dantas Sousa PH, Costa AF, de Menezes LB, Alves SF, Pellegrini F, et al. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model. Med Mycol. 2023;61:myad113. https:\/\/doi.org\/10.1093\/mmy\/myad113.","journal-title":"Med Mycol"},{"key":"3312_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2174\/1389201022666210708105142","volume":"23","author":"N Saleh","year":"2022","unstructured":"Saleh N, Elshaer S, Girgis G. Biodegradable polymers-based nanoparticles to enhance the antifungal efficacy of fluconazole against Candida albicans. Curr Pharm Biotechnol. 2022;23:749\u201357. https:\/\/doi.org\/10.2174\/1389201022666210708105142.","journal-title":"Curr Pharm Biotechnol"},{"key":"3312_CR47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.12.139","volume":"227","author":"H Kolge","year":"2023","unstructured":"Kolge H, Patil G, Jadhav S, Ghormade V. A pH-tuned chitosan-PLGA nanocarrier for fluconazole delivery reduces toxicity and improves efficacy against resistant Candida. Int J Biol Macromol. 2023;227:453\u201361. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.12.139.","journal-title":"Int J Biol Macromol"},{"key":"3312_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101306","volume":"16","author":"A Tikhonov","year":"2024","unstructured":"Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I, et al. Biomimetic nanoparticles for basic drug delivery. Pharmaceutics. 2024;16: 1306. https:\/\/doi.org\/10.3390\/pharmaceutics16101306.","journal-title":"Pharmaceutics"},{"key":"3312_CR49","doi-asserted-by":"publisher","unstructured":"Srivastava R, Debnath SK, Prasad R. Nanomaterials in Healthcare [Internet]. 1st ed. Boca Raton: CRC Press; 2023 [cited 2025 Oct 5]. https:\/\/doi.org\/10.1201\/9781003322368.","DOI":"10.1201\/9781003322368"},{"key":"3312_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/10837450.2024.2350530","volume":"29","author":"A Pe\u0161t\u00e1lov\u00e1","year":"2024","unstructured":"Pe\u0161t\u00e1lov\u00e1 A, Gajdziok J. Modern trends in the formulation of microparticles for lung delivery using porogens: methods, principles and examples. Pharm Dev Technol. 2024;29:504\u201316. https:\/\/doi.org\/10.1080\/10837450.2024.2350530.","journal-title":"Pharm Dev Technol"},{"key":"3312_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/life13051099","volume":"13","author":"L Kumari","year":"2023","unstructured":"Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, et al. Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs. Life. 2023;13: 1099. https:\/\/doi.org\/10.3390\/life13051099.","journal-title":"Life"},{"key":"3312_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","volume":"12","author":"VVSNL Andra","year":"2022","unstructured":"Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. BioNanoScience. 2022;12:274\u201391. https:\/\/doi.org\/10.1007\/s12668-022-00941-x.","journal-title":"BioNanoScience"},{"key":"3312_CR53","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/AAC.01630-08","volume":"53","author":"C Sheng","year":"2009","unstructured":"Sheng C, Miao Z, Ji H, Yao J, Wang W, Che X, et al. Three-dimensional model of lanosterol 14\u03b1-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother. 2009;53:3487\u201395. https:\/\/doi.org\/10.1128\/AAC.01630-08.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03312-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:46:40Z","timestamp":1772228800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03312-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03312-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they comply with ethical standards. Experimental animals and humans were not used in this study. Therefore, an ethical permit was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standarts"}},{"value":"The authors declared that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"81"}}